Tech Company Financing Transactions
Western Oncolytics Funding Round
Western Oncolytics, based in Pittsburgh, secured $275 thousand from private investors.
Transaction Overview
Company Name
Announced On
6/20/2014
Transaction Type
Venture Equity
Amount
$275,000
Round
Seed
Investors
Proceeds Purpose
The company intends to use the funds for clinical trials and execute initial manufacturing for its novel virus-based cancer therapy.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
265 William Pitt Way
Pittsburgh, PA 15238
USA
Pittsburgh, PA 15238
USA
Phone
Website
Email Address
Overview
Western Oncolytics Ltd. develops therapies for cancer. It develops WO-12, an immuno-oncolytic therapy that stimulates a directed immune attack against cancer while removing blocks to immune activity in tumor environments, as well as works in combination with other therapies.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Stephen Thorne
Chief Financial Officer
Ian Magazine
Chief Operating Officer
Helena Chaye
VP - Bus. Development
Katy Wack
VP - General Counsel
Elizabeth Duckett
Browse more venture capital transactions:
Prev: 6/20/2014: JHL Biotech venture capital transaction
Next: 6/20/2014: Airspan Networks venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to record every notable VC transaction. VC transactions on this site are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs